Sanket Koul

West Asia conflict pushes housing sales in metros down 6% in Apr-Jun

Residential sales across the top seven cities fell to 90,715 units in Q2 2026, while new launches rose 7 per cent as developers continued to add inventory despite uncertainty

CDSCO tightens IVF reagent sale norms, restricts supplies to ART clinics

The drug regulator has directed manufacturers and distributors to supply IVF media and reagents only to registered ART clinics, strengthening oversight of assisted reproductive technologies

Ola entities renew lease for 430,000 sq ft office space in Bengaluru

Ola Electric Technologies and ANI Technologies have renewed separate leases for 430,000 sq ft at Bengaluru's Prestige RMZ Star Tech campus with a combined rental of Rs 281.11 crore

Govt plans easing licence timelines for moderate, high-risk medical devices

Draft amendments to the Medical Device Rules seek to reduce manufacturing licence timelines for Class B, C and D devices to improve regulatory efficiency and ease of doing business

Centre proposes easing shelf-life, licensing norms for imported drugs

Draft amendments propose a 12-month minimum residual shelf life for imported drugs and an acknowledgement-based mechanism for importing medicines for research

Centre scraps Jackson Labs' licences amid Rajasthan maternal deaths probe

WHO has sought additional information after reports linked suspected fake oxytocin injections to maternal deaths in Rajasthan, while the Centre cancelled the firm's licences

Eli Lilly launches its first solid tumour RET-gene therapy in India

The US drugmaker has launched Tanstrive, a RET-targeted oral therapy for advanced or metastatic solid tumours, following marketing authorisation from the CDSCO

Hero MotoCorp, WeWork lease 3.5 lakh sq ft in Worldmark for ₹922 crore

Hero MotoCorp and WeWork have signed separate long-term office leases at Bharti Real Estate's Worldmark complex in Aerocity, with a combined rental outlay of about Rs 922 crore

Centre brings vaccines, anti-cancer drugs under QR code tracking regime

The Health Ministry will expand mandatory QR code-based traceability to vaccines, antimicrobials, anti-cancer, narcotic and psychotropic drugs in a phased rollout

Submit quarterly data on essential medicines: NPPA tells drugmakers

The drug pricing regulator has directed manufacturers to regularly furnish production and sales data for scheduled formulations to strengthen monitoring of essential medicines

Manglam Group ties up with Marriott for ₹350 crore Sheraton hotel in Jaipur

The 220-key luxury hotel on the Jaipur-Ajmer Highway is part of Manglam Group's broader Rs 1,000 crore hospitality investment plan over five years

National developers expand footprint in Delhi-NCR housing market

Share of national developers in Delhi-NCR's residential supply has risen from 3 per cent in 2022 to over 13 per cent, driven by premium housing demand and infrastructure growth

Centre mandates periodic renewal of IVF, ART and surrogacy clinics

Centre mandates periodic renewal of registrations for ART and surrogacy clinics to strengthen oversight, improve compliance, and boost patient confidence

Accenture leases 1 mn sq ft office space in Hyderabad for over ₹1,000 crore

The company has also deposited Rs 29.5 crore as security, with the lease including a 4.25 per cent rent escalation every year

Centre seeks stakeholder views on medical devices exempt from GTE norms

Department of Pharmaceuticals invites stakeholder comments on proposed additions and deletions to the list of medical devices exempted from Global Trade Enquiry requirements

Smartworks renews lease for 2.3 lakh sq ft office space in Hyderabad

Co-working and flex-space provider commits Rs 121 crore over five years for Hyderabad office space as it pursues expansion across key urban and Tier-I markets

Government bans 16 fixed drug combinations over health safety concerns

Health Ministry prohibits 16 fixed drug combinations, including antibiotic and cosmetic formulations, after an expert review found they lacked therapeutic justification and posed potential health risk

CDSCO prohibits clinical trials at KKR-backed HCG cancer hospital

Drug regulator alleges irregularities in reporting adverse events and conflict-of-interest disclosures by the unit's ethics committee during human clinical trials

Namo Cities: Delhi's decongestion dream faces the test of execution

Experts flag coordination gaps as Centre bets on transit-led satellite hubs

Target India signs ₹1,250-crore Bengaluru office lease for GCC expansion

The retailer's India arm has leased 8.3 lakh sq ft at Embassy Manyata Business Park, reinforcing Bengaluru's position as the leading hub for GCC-led office demand